or Try an Advanced Search...

    Technical Analysis for MGRX - Mangoceuticals, Inc.

    Grade Last Price % Change Price Change
    C 0.43 2.38% 0.01
    MGRX closed up 2.38 percent on Friday, July 26, 2024, on 30 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Up
    Historical MGRX trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Pocket Pivot Bullish Swing Setup 2.38%
    Wide Bands Range Expansion 2.38%
    Upper Bollinger Band Touch Strength 2.38%
    Wide Bands Range Expansion 6.97%
    50 DMA Support Bullish 2.63%
    Crossed Above 200 DMA Bullish 2.63%
    Wide Bands Range Expansion 2.63%
    Older End-of-Day Signals for MGRX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band about 16 hours ago
    Up 5% about 16 hours ago
    Up 3% about 16 hours ago
    Up 2% about 16 hours ago
    Up 1% about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MGRX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Telehealth Telemedicine Wellness Products Erectile Dysfunction

    Is MGRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 24 MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
    Jul 18 Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
    Jul 16 MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
    Jul 12 MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department
    Jul 11 MangoRx signs partnership for expansion into Asia Pacific, China and Latin America
    Jul 11 MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
    Jun 6 MangoRx gets notice of acceptance for patent application in Australia
    Jun 6 MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
    Jun 4 Mangoceuticals stock rallies on Japanese patent allowance
    Jun 4 MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies
    See more MGRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.58
    52 Week Low 0.143
    Average Volume 7,017,767
    200-Day Moving Average 0.38
    50-Day Moving Average 0.36
    20-Day Moving Average 0.37
    10-Day Moving Average 0.40
    Average True Range 0.05
    RSI (14) 60.32
    ADX 51.73
    +DI 32.74
    -DI 7.60
    Chandelier Exit (Long, 3 ATRs) 0.32
    Chandelier Exit (Short, 3 ATRs) 0.44
    Upper Bollinger Bands 0.45
    Lower Bollinger Band 0.28
    Percent B (%b) 0.86
    BandWidth 48.03
    MACD Line 0.02
    MACD Signal Line 0.01
    MACD Histogram 0.0061
    Fundamentals Value
    Market Cap 9.47 Million
    Num Shares 22 Million
    EPS -0.44
    Price-to-Earnings (P/E) Ratio -0.98
    Price-to-Sales 12.35
    Price-to-Book 6.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.50
    Resistance 3 (R3) 0.50 0.48 0.49
    Resistance 2 (R2) 0.48 0.46 0.48 0.49
    Resistance 1 (R1) 0.45 0.45 0.47 0.45 0.48
    Pivot Point 0.43 0.43 0.44 0.43 0.43
    Support 1 (S1) 0.41 0.41 0.42 0.41 0.38
    Support 2 (S2) 0.38 0.40 0.38 0.37
    Support 3 (S3) 0.36 0.38 0.37
    Support 4 (S4) 0.36